Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease. (2026). Cardiology and Cardiovascular Medicine, 10(2), 71-78. https://fortunejournals.org/ojs/index.php/ccm/article/view/16687